Exploring the US FDA's Upcoming Complex Generic Product-Specific Guidance Lists

 
• By Derrick Gingery

The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.

RulesRegulationsBooks_1200x675
The US FDA issued more revised than new product-specific guidances for generic products in fiscal year 2019, unlike past fiscal years. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics